X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
humans (15) 15
female (13) 13
male (12) 12
middle aged (11) 11
aged (10) 10
cardiac & cardiovascular systems (9) 9
stents (9) 9
surgical implants (7) 7
implantation (6) 6
treatment outcome (6) 6
biocompatibility (5) 5
biomedical materials (5) 5
cardiology (5) 5
coronary artery (5) 5
coronary vessels (5) 5
adult (4) 4
aged, 80 and over (4) 4
cardiovascular disease (4) 4
care and treatment (4) 4
coronary heart disease (4) 4
heart attacks (4) 4
italy (4) 4
lesions (4) 4
oncology (4) 4
risk factors (4) 4
stent (4) 4
surgery (4) 4
time factors (4) 4
abridged index medicus (3) 3
angioplasty (3) 3
anthropology (3) 3
biology (3) 3
cancer (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
cardiovascular (3) 3
chemotherapy (3) 3
clinical trials (3) 3
clinical-outcomes (3) 3
coronary angiography (3) 3
disease (3) 3
erlotinib hydrochloride (3) 3
follow-up (3) 3
gefitinib (3) 3
genetic aspects (3) 3
health aspects (3) 3
kaplan-meier estimate (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - mortality (3) 3
medicine & public health (3) 3
multivariate analysis (3) 3
mutation (3) 3
percutaneous coronary intervention (3) 3
prospective studies (3) 3
receptor, epidermal growth factor - genetics (3) 3
success (3) 3
tumors (3) 3
young adult (3) 3
acute myocardial infarction (2) 2
analysis (2) 2
antibody-drug conjugate (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antitumor-activity (2) 2
cancer therapies (2) 2
carboplatin (2) 2
carcinoma (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dissection (2) 2
dna, mitochondrial - genetics (2) 2
drug administration schedule (2) 2
earth sciences (2) 2
egfr mutations (2) 2
emtansine (2) 2
erlotinib (2) 2
europe (2) 2
feasibility studies (2) 2
genetic variation (2) 2
geosciences, multidisciplinary (2) 2
hematology, oncology and palliative medicine (2) 2
her2 (2) 2
hospitals (2) 2
impact (2) 2
implants (2) 2
internal medicine (2) 2
intervention (2) 2
lung cancer (2) 2
lung cancer, non-small cell (2) 2
magnesium (2) 2
management (2) 2
medical research (2) 2
metastases (2) 2
molecular targeted therapy (2) 2
optical coherence tomography (2) 2
patients (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 18, pp. B152 - B153
Device acute success was defined as 1) successful BRS delivery and implantation 2) post-procedural residual diameter stenosis <30% within the treated segment;... 
Surgical implants | Biocompatibility | Implantation | Biomedical materials | Stents | Success
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A1110 - A1110
Device acute success defined as 1) successful BrS delivery and implantation 2) post-procedural residual diameter stenosis <20% within the treated segment; 3)... 
Surgical implants | Biomedical materials | Biocompatibility | Implantation | Lesions | Stents | Success
Journal Article
Journal Article
Cardiovascular Intervention and Therapeutics, ISSN 1868-4300, 4/2017, Volume 32, Issue 2, pp. 186 - 189
We reported a case of a fit and active 48 years’ old woman presented with acute coronary syndrome due to a spontaneous coronary dissection (SCAD) treated with... 
Bioresorbable scaffolds | Interventional Radiology | Medicine & Public Health | Spontaneous coronary dissection | Cardiology | Intravascular ultrasounds imaging | Coronary heart disease | Surgery
Journal Article